KR19990067219A - 트롬빈 억제제 - Google Patents
트롬빈 억제제 Download PDFInfo
- Publication number
- KR19990067219A KR19990067219A KR1019980703176A KR19980703176A KR19990067219A KR 19990067219 A KR19990067219 A KR 19990067219A KR 1019980703176 A KR1019980703176 A KR 1019980703176A KR 19980703176 A KR19980703176 A KR 19980703176A KR 19990067219 A KR19990067219 A KR 19990067219A
- Authority
- KR
- South Korea
- Prior art keywords
- pro
- lys
- phe
- boc
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95202982.5 | 1995-11-03 | ||
| EP95202982 | 1995-11-03 | ||
| EP95203554 | 1995-12-19 | ||
| EP95203554.1 | 1995-12-19 | ||
| PCT/EP1996/004785 WO1997017363A1 (en) | 1995-11-03 | 1996-10-30 | Thrombin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR19990067219A true KR19990067219A (ko) | 1999-08-16 |
Family
ID=26139759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019980703176A Ceased KR19990067219A (ko) | 1995-11-03 | 1996-10-30 | 트롬빈 억제제 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6432921B2 (https=) |
| EP (1) | EP0858464B1 (https=) |
| JP (1) | JPH11515033A (https=) |
| KR (1) | KR19990067219A (https=) |
| CN (1) | CN1202902A (https=) |
| AR (1) | AR004254A1 (https=) |
| AT (1) | ATE239755T1 (https=) |
| AU (1) | AU712940B2 (https=) |
| BR (1) | BR9611377A (https=) |
| CA (1) | CA2235586A1 (https=) |
| CZ (1) | CZ133998A3 (https=) |
| DE (1) | DE69628027T2 (https=) |
| DK (1) | DK0858464T3 (https=) |
| ES (1) | ES2199302T3 (https=) |
| HU (1) | HUP9900728A3 (https=) |
| IL (1) | IL119466A (https=) |
| NO (1) | NO981965L (https=) |
| PL (1) | PL326863A1 (https=) |
| PT (1) | PT858464E (https=) |
| RU (1) | RU2178796C2 (https=) |
| TR (1) | TR199800773T2 (https=) |
| TW (1) | TW486459B (https=) |
| WO (1) | WO1997017363A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL121474A0 (en) * | 1996-08-23 | 1998-02-08 | Akzo Nobel Nv | Thrombin inhibitors |
| JP2001504810A (ja) * | 1996-10-11 | 2001-04-10 | シーオーアール・セラピューティックス・インコーポレーテッド | 選択的第Xa因子阻害剤 |
| US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
| US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
| US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| WO1998046628A1 (en) * | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| NZ500354A (en) | 1997-04-14 | 2001-11-30 | Cor Therapeutics Inc | Cyclic diaza compounds as selective factor Xa inhibitors for treating thrombotic related disorders |
| US6369063B1 (en) | 1997-04-14 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| AU6896298A (en) | 1997-04-14 | 1998-11-11 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
| EP0884325A1 (en) * | 1997-04-24 | 1998-12-16 | Akzo Nobel N.V. | Thrombin inhibitors containing a peptidyl heterocycle |
| US5877156A (en) * | 1997-04-24 | 1999-03-02 | Akzo Nobel, N.V. | Thrombin inhibitors |
| NZ500620A (en) * | 1997-05-02 | 2000-10-27 | Akzo Nobel Nv | Synthetic peptides which inhibit serine proteases, specifically thrombin, factor VIIa tissue factor and factor Xa |
| JP2001525823A (ja) | 1997-05-15 | 2001-12-11 | イーライ・リリー・アンド・カンパニー | 抗血栓化合物 |
| US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
| US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| TR200102766T2 (tr) * | 1999-01-27 | 2001-12-21 | Ortho-Mcneil Pharmaceutical, Inc. | Triptaz inhibitörü olarak kullanılan peptidil heterosiklik ketonlar |
| US6344450B1 (en) * | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
| US7405210B2 (en) * | 2003-05-21 | 2008-07-29 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| DE602005023965D1 (de) | 2004-03-08 | 2010-11-18 | Prosidion Ltd | Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase |
| PT1737889E (pt) | 2004-10-19 | 2010-12-13 | Lonza Ag | Método para síntese de péptidos em fase sólida |
| ATE424821T1 (de) | 2004-12-02 | 2009-03-15 | Prosidion Ltd | Pyrrolopyridin-2-karbonsäureamide |
| CA2651762A1 (en) | 2006-05-23 | 2007-11-29 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| AU2008214217B2 (en) | 2007-02-09 | 2011-10-13 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| SG187271A1 (en) * | 2011-07-07 | 2013-02-28 | Agency Science Tech & Res | Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic |
| PT3204352T (pt) * | 2014-10-06 | 2020-09-23 | Cortexyme Inc | Inibidores de lisina-gingipaína |
| CA3004095A1 (en) | 2015-11-09 | 2017-05-18 | Cortexyme, Inc. | Inhibitors of arginine gingipain |
| ES2992410T3 (es) | 2016-09-16 | 2024-12-12 | Lighthouse Pharmaceuticals Inc | Inhibidores cetónicos de la lisina gingipaína |
| TWI837089B (zh) | 2017-05-25 | 2024-04-01 | 南韓商Jw製藥公司 | 製備雜環衍生化合物之方法、包括該化合物之組成物及該化合物之水合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9110298D0 (en) * | 1991-05-13 | 1991-07-03 | Fujisawa Pharmaceutical Co | New peptide compound and a process for the preparation thereof |
| WO1996019483A1 (en) * | 1994-12-22 | 1996-06-27 | Biochem Pharma Inc. | Low molecular weight bicyclic thrombin inhibitors |
| US5827860A (en) * | 1995-06-07 | 1998-10-27 | Ortho Pharmaceutical Corporation | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| US5523308A (en) * | 1995-06-07 | 1996-06-04 | Costanzo; Michael J. | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| US5827866A (en) * | 1995-06-07 | 1998-10-27 | Ortho Pharmaceutical Corporation | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
-
1996
- 1996-10-22 IL IL11946696A patent/IL119466A/xx not_active IP Right Cessation
- 1996-10-30 EP EP96937337A patent/EP0858464B1/en not_active Expired - Lifetime
- 1996-10-30 AU AU74975/96A patent/AU712940B2/en not_active Ceased
- 1996-10-30 AT AT96937337T patent/ATE239755T1/de not_active IP Right Cessation
- 1996-10-30 JP JP9517828A patent/JPH11515033A/ja not_active Ceased
- 1996-10-30 WO PCT/EP1996/004785 patent/WO1997017363A1/en not_active Ceased
- 1996-10-30 TR TR1998/00773T patent/TR199800773T2/xx unknown
- 1996-10-30 KR KR1019980703176A patent/KR19990067219A/ko not_active Ceased
- 1996-10-30 US US09/068,074 patent/US6432921B2/en not_active Expired - Fee Related
- 1996-10-30 DK DK96937337T patent/DK0858464T3/da active
- 1996-10-30 ES ES96937337T patent/ES2199302T3/es not_active Expired - Lifetime
- 1996-10-30 PT PT96937337T patent/PT858464E/pt unknown
- 1996-10-30 PL PL96326863A patent/PL326863A1/xx unknown
- 1996-10-30 CZ CZ981339A patent/CZ133998A3/cs unknown
- 1996-10-30 BR BR9611377A patent/BR9611377A/pt unknown
- 1996-10-30 RU RU98110641/04A patent/RU2178796C2/ru not_active IP Right Cessation
- 1996-10-30 CN CN96198628A patent/CN1202902A/zh active Pending
- 1996-10-30 DE DE69628027T patent/DE69628027T2/de not_active Expired - Fee Related
- 1996-10-30 HU HU9900728A patent/HUP9900728A3/hu unknown
- 1996-10-30 CA CA002235586A patent/CA2235586A1/en not_active Abandoned
- 1996-11-01 AR ARP960104997A patent/AR004254A1/es unknown
- 1996-11-04 TW TW085113438A patent/TW486459B/zh active
-
1998
- 1998-04-30 NO NO981965A patent/NO981965L/no not_active Application Discontinuation
-
2002
- 2002-01-04 US US10/039,737 patent/US20020142967A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020142967A1 (en) | 2002-10-03 |
| MX9803479A (es) | 1998-09-30 |
| DK0858464T3 (da) | 2003-08-25 |
| EP0858464B1 (en) | 2003-05-07 |
| HUP9900728A3 (en) | 2000-12-28 |
| TR199800773T2 (xx) | 1998-08-21 |
| HUP9900728A2 (hu) | 1999-08-30 |
| ES2199302T3 (es) | 2004-02-16 |
| PT858464E (pt) | 2003-08-29 |
| IL119466A0 (en) | 1997-01-10 |
| CZ133998A3 (cs) | 1998-09-16 |
| WO1997017363A1 (en) | 1997-05-15 |
| US6432921B2 (en) | 2002-08-13 |
| AU7497596A (en) | 1997-05-29 |
| DE69628027D1 (en) | 2003-06-12 |
| CA2235586A1 (en) | 1997-05-15 |
| CN1202902A (zh) | 1998-12-23 |
| EP0858464A1 (en) | 1998-08-19 |
| JPH11515033A (ja) | 1999-12-21 |
| PL326863A1 (en) | 1998-10-26 |
| US20010007764A1 (en) | 2001-07-12 |
| IL119466A (en) | 2001-08-26 |
| AR004254A1 (es) | 1998-11-04 |
| TW486459B (en) | 2002-05-11 |
| BR9611377A (pt) | 1999-02-23 |
| AU712940B2 (en) | 1999-11-18 |
| NO981965L (no) | 1998-06-30 |
| DE69628027T2 (de) | 2004-04-08 |
| NO981965D0 (no) | 1998-04-30 |
| RU2178796C2 (ru) | 2002-01-27 |
| ATE239755T1 (de) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR19990067219A (ko) | 트롬빈 억제제 | |
| US6218365B1 (en) | Serine protease inhibitors | |
| US6034067A (en) | Serine protease inhibitors | |
| US6410684B1 (en) | Serine protease inhibitors | |
| WO1993025574A1 (en) | Inhibitors of angiotensin i chymase(s) including human heart chymase | |
| EP0956293B1 (en) | Thrombin inhibitors | |
| WO1997012904A1 (en) | Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors | |
| US5877156A (en) | Thrombin inhibitors | |
| MXPA98003479A (en) | Tromb inhibitors | |
| EP0884325A1 (en) | Thrombin inhibitors containing a peptidyl heterocycle | |
| RU2172321C2 (ru) | Ингибиторы сериновых протеаз | |
| HK1021541B (en) | Serine protease inhibitors | |
| MXPA98007091A (en) | Inhibitors of protease being | |
| MXPA98007090A (en) | Inhibitors of serine prote |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19980430 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20011029 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20040206 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20040503 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20040206 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |